MedPath

NOVOXAPAM TAB 30MG

NOVOXAPAM TAB 30MG

Discontinued
DIN Number

00496537

Drug Class

Human

Market Date

Dec 31, 1982

Company
HC

novopharm limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00496537
AIG Number0102420001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA04 OXAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

OXAZEPAMActive
Strength: 30 MG
Monograph: OXAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.